GlassScriptPhysician profile
Richard M Bennett
NPI 1891709663
$4,212.48
in general payments reported to CMS, 2019-2025
44 companies · $50.67 in 2025
The $50.67 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,010 · 2020: $341 · 2021: $233 · 2022: $816 · 2023: $1,077 · 2024: $685 · 2025: $50.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $377.08 | 2023-2024 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $316.07 | 2019-2023 | Xtandi |
| Abbvie INC. | $307.67 | 2019-2024 | Botox, Lupron Depot |
| Endo Pharmaceuticals INC. | $297.00 | 2019-2022 | |
| Antares Pharma, INC. | $220.61 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $212.47 | 2019-2025 | Speedicath |
| Pfizer INC. | $168.16 | 2019-2024 | |
| Procept Biorobotics Corporation | $149.12 | 2023 | Aquabeam Robotic System |
| Myriad Genetic Laboratories, INC. | $143.70 | 2021-2023 | Prolaris |
| Novartis Pharmaceuticals Corporation | $135.05 | 2019-2023 | |
| Blue Earth Diagnostics | $114.02 | 2019 | |
| Janssen Biotech, INC. | $112.13 | 2019-2023 | Erleada |
| Halozyme INC | $101.37 | 2023 | |
| Photocure INC | $98.17 | 2019 | |
| Ferring Pharmaceuticals INC. | $97.82 | 2019-2024 | Adstiladrin |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.